ALEXANDRIA, Va., June 12 -- United States Patent no. 12,295,362, issued on May 13, was assigned to Allogene Therapeutics Inc. (South San Francisco, Calif.).
"Formulations and processes for CAR T cell drug products" was invented by Muneeswara Babu Medi (Chalfont, Pa.), Zhuojin Xu (San Francisco), Jung S. Lee (South San Francisco, Calif.), Yajin Ni (San Diego) and Mark W. Leonard (Burlingame, Calif.).
According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are formulations and drug product processes that can improve cell viability and minimize waste of the manufactured formulated cells for a drug product."
The patent was filed on Feb. 3, 2022, under Application No. 17/592,105.
*For further information, ...